SAMe Equals Rx Drugs in Treatment of Depression
A recent literature review of S-Adenosyl-methionine (SAMe) is shedding new light on this unique compound in the treatment of depression and other neuropsychiatric disorders. In some studies, SAMe was equivalent in efficacy to Tricyclic Antidepressants (TCAs) and Selective Serotonin Reuptake Inhibitors (SSRIs) in reducing symptoms and improving quality of life.